NCT02423811View on ClinicalTrials.gov

Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Cancer Stem Cell
Interventions
DIETARY_SUPPLEMENT

Fursultiamine

Use of Fursultiamine in addition to CCRT

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER

NCT02423811 - Fursultiamine in Esophageal Squamous Cell Carcinoma Patients Who Receive Concurrent Chemoradiotherapy | Biotech Hunter | Biotech Hunter